• Most Popular
  • Most Shared

Bavarian to start Phase III prostate cancer vaccine

Tue Oct 7, 2008 2:19am EDT

Stocks

   

COPENHAGEN, Oct 7 (Reuters) - Danish vaccine maker Bavarian Nordic (BAVA.CO) said on Tuesday it would start a Phase III study in 2010 for its prostate cancer vaccine after the Phase II study data was positive. The Phase II data for the Prostvac vaccine showed statistically significant improved overall survival in a sample of 125 patients.

Patients treated with the vaccine had a longer median overall survival by 8.5 months compared to the placebo group.

The current approved treatment for advanced prostate cancer extends median overall survival by about 2 months, Bavarian said. (Reporting by Gelu Sulugiuc; Editing by David Cowell)



More from Reuters

Joint Terminal Attack Controller SSgt Clinton J. Herbison, a U.S. Airman from the 817 Expeditionary Air Support Operations Squadron (EASOS) takes a break during a night mission near Honaker Miracle camp at the Pesh valley of Kunar Province August 12, 2009. Credit: REUTERS/Carlos Barria

Pictures of the Year

A look at the best photos of 2009.  Slideshow 

    PICTURES
    The Dalai Lama jokes with a nasal spray after being asked his opinion on the swine flu during a press conference after his first lecture in Lausanne, Switzerland, August 4, 2009. REUTERS/ Valentin Flauraud

    What a wacky year it's been...

    Um, what's up the Dalai Lama's nose? "Oddly Enough" editor Bob Basler rounds up the goofiest photos of the year.  Full Article 

    Oddly Enough
    A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
    Political Risk in 2010:

    Don't say we didn't warn you

    With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article 

    Global Markets